Spero Therapeutics to Present at Upcoming Investor

Spero Therapeutics to Present at Upcoming Investor

CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical......

menu
menu